Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

RATIONALE & OBJECTIVE: In FIDELITY, finerenone improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). This analysis explored the efficacy and safety of finerenone in Black patients. STUDY DESIGN: Subanalysis of randomized controlled trials. SETTING...

Descripción completa

Detalles Bibliográficos
Autores principales: Flack, John M., Agarwal, Rajiv, Anker, Stefan D., Pitt, Bertram, Ruilope, Luis M., Rossing, Peter, Adler, Sharon G., Fried, Linda, Jamerson, Kenneth, Toto, Robert, Brinker, Meike, Farjat, Alfredo E., Kolkhof, Peter, Lawatscheck, Robert, Joseph, Amer, Bakris, George L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692708/
https://www.ncbi.nlm.nih.gov/pubmed/38046911
http://dx.doi.org/10.1016/j.xkme.2023.100730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692708/
https://www.ncbi.nlm.nih.gov/pubmed/38046911
http://dx.doi.org/10.1016/j.xkme.2023.100730

Ejemplares similares